International Society of Glomerular Disease
@isgd.bsky.social
We’re a professional society for glomerular disease experts, founded in 2022.
https://is-gd.org
https://is-gd.org
Importance of surrogate endpoints - focus on Proteinuria! @ASNKidney
▶️ Proteinuria and Podocyte loss mechanisms 🐙
▶️ Accelerated drug approval 🚀
▶️ A call to Action! by @kirkcampbell - PARASOL results and future expansion 🌟
#KidneyWk #ISGDTweets #GlomerularDisease
▶️ Proteinuria and Podocyte loss mechanisms 🐙
▶️ Accelerated drug approval 🚀
▶️ A call to Action! by @kirkcampbell - PARASOL results and future expansion 🌟
#KidneyWk #ISGDTweets #GlomerularDisease
November 8, 2025 at 9:38 PM
Importance of surrogate endpoints - focus on Proteinuria! @ASNKidney
▶️ Proteinuria and Podocyte loss mechanisms 🐙
▶️ Accelerated drug approval 🚀
▶️ A call to Action! by @kirkcampbell - PARASOL results and future expansion 🌟
#KidneyWk #ISGDTweets #GlomerularDisease
▶️ Proteinuria and Podocyte loss mechanisms 🐙
▶️ Accelerated drug approval 🚀
▶️ A call to Action! by @kirkcampbell - PARASOL results and future expansion 🌟
#KidneyWk #ISGDTweets #GlomerularDisease
Oral Abstract Session 🌟
▶️ The greater the reduction in Proteinuria, the better the outcomes in IgA Nephropathy! 🔑
▶️ Outcomes across diseases and age in the CureGN cohort! 👏
#KidneyWk #ISGDTweets #GlomerularDisease
▶️ The greater the reduction in Proteinuria, the better the outcomes in IgA Nephropathy! 🔑
▶️ Outcomes across diseases and age in the CureGN cohort! 👏
#KidneyWk #ISGDTweets #GlomerularDisease
November 8, 2025 at 12:46 AM
Oral Abstract Session 🌟
▶️ The greater the reduction in Proteinuria, the better the outcomes in IgA Nephropathy! 🔑
▶️ Outcomes across diseases and age in the CureGN cohort! 👏
#KidneyWk #ISGDTweets #GlomerularDisease
▶️ The greater the reduction in Proteinuria, the better the outcomes in IgA Nephropathy! 🔑
▶️ Outcomes across diseases and age in the CureGN cohort! 👏
#KidneyWk #ISGDTweets #GlomerularDisease
Outstandining talk by @AstridWeins on anti-nephrin antibodies
▶️ Anti-nephrin Ab provides diagnostic value, guide treatment and define prognosis
▶️ Refined techniques and appropriate treatment-related timing measurement is crucial 🧪
#KidneyWk #ISGDTweets #GlomerularDisease
▶️ Anti-nephrin Ab provides diagnostic value, guide treatment and define prognosis
▶️ Refined techniques and appropriate treatment-related timing measurement is crucial 🧪
#KidneyWk #ISGDTweets #GlomerularDisease
November 7, 2025 at 10:01 PM
Outstandining talk by @AstridWeins on anti-nephrin antibodies
▶️ Anti-nephrin Ab provides diagnostic value, guide treatment and define prognosis
▶️ Refined techniques and appropriate treatment-related timing measurement is crucial 🧪
#KidneyWk #ISGDTweets #GlomerularDisease
▶️ Anti-nephrin Ab provides diagnostic value, guide treatment and define prognosis
▶️ Refined techniques and appropriate treatment-related timing measurement is crucial 🧪
#KidneyWk #ISGDTweets #GlomerularDisease
Innovative initiatives in Pediatric NS!
▶️ PARASOL provides a regulatory path for new drugs by proving proteinuria as a marker 🌟 and is expanding to APOL-1-mediated KD and MN! 🚀
▶️ NEPTUNE Match moving towards personalized medicine 🎯
#KidneyWk #ISGDTweets #GlomerularDisease
▶️ PARASOL provides a regulatory path for new drugs by proving proteinuria as a marker 🌟 and is expanding to APOL-1-mediated KD and MN! 🚀
▶️ NEPTUNE Match moving towards personalized medicine 🎯
#KidneyWk #ISGDTweets #GlomerularDisease
November 7, 2025 at 9:40 PM
Innovative initiatives in Pediatric NS!
▶️ PARASOL provides a regulatory path for new drugs by proving proteinuria as a marker 🌟 and is expanding to APOL-1-mediated KD and MN! 🚀
▶️ NEPTUNE Match moving towards personalized medicine 🎯
#KidneyWk #ISGDTweets #GlomerularDisease
▶️ PARASOL provides a regulatory path for new drugs by proving proteinuria as a marker 🌟 and is expanding to APOL-1-mediated KD and MN! 🚀
▶️ NEPTUNE Match moving towards personalized medicine 🎯
#KidneyWk #ISGDTweets #GlomerularDisease
Pediatric Nephrotic Syndrome Translational Session
▶️ Diverse Immunological Architecture!
▶️ Recent focus on novel autoantibodies 🎯
▶️ GWAS + composite HLA-PRS in the search of a unified disease mechanism 🧬
#KidneyWk #ISGDTweets #GlomerularDisease
▶️ Diverse Immunological Architecture!
▶️ Recent focus on novel autoantibodies 🎯
▶️ GWAS + composite HLA-PRS in the search of a unified disease mechanism 🧬
#KidneyWk #ISGDTweets #GlomerularDisease
November 7, 2025 at 9:29 PM
Pediatric Nephrotic Syndrome Translational Session
▶️ Diverse Immunological Architecture!
▶️ Recent focus on novel autoantibodies 🎯
▶️ GWAS + composite HLA-PRS in the search of a unified disease mechanism 🧬
#KidneyWk #ISGDTweets #GlomerularDisease
▶️ Diverse Immunological Architecture!
▶️ Recent focus on novel autoantibodies 🎯
▶️ GWAS + composite HLA-PRS in the search of a unified disease mechanism 🧬
#KidneyWk #ISGDTweets #GlomerularDisease
B-cell depleting strategies in lupus nephritis 🐺
▶️ Obinutuzumab confers higher complete remission rates vs other mAbs
▶️ Immunological reset 🆕 CAR-T cells - deeper depletion in varied differentiation stages (for refractory cases!)
#KidneyWk #ISGDtweets #GlomerularDisease
▶️ Obinutuzumab confers higher complete remission rates vs other mAbs
▶️ Immunological reset 🆕 CAR-T cells - deeper depletion in varied differentiation stages (for refractory cases!)
#KidneyWk #ISGDtweets #GlomerularDisease
November 7, 2025 at 8:55 PM
B-cell depleting strategies in lupus nephritis 🐺
▶️ Obinutuzumab confers higher complete remission rates vs other mAbs
▶️ Immunological reset 🆕 CAR-T cells - deeper depletion in varied differentiation stages (for refractory cases!)
#KidneyWk #ISGDtweets #GlomerularDisease
▶️ Obinutuzumab confers higher complete remission rates vs other mAbs
▶️ Immunological reset 🆕 CAR-T cells - deeper depletion in varied differentiation stages (for refractory cases!)
#KidneyWk #ISGDtweets #GlomerularDisease
The role of B-cells in lupus nephritis by @AugustoVaglio 🐺
▶️ B-cell activation and expanison
▶️ B-cell overdifferentiation and hiperreactivity
▶️ Isolated germinal centers
#KidneyWk #ISGDtweets #GlomerularDisease
▶️ B-cell activation and expanison
▶️ B-cell overdifferentiation and hiperreactivity
▶️ Isolated germinal centers
#KidneyWk #ISGDtweets #GlomerularDisease
November 7, 2025 at 8:35 PM
The role of B-cells in lupus nephritis by @AugustoVaglio 🐺
▶️ B-cell activation and expanison
▶️ B-cell overdifferentiation and hiperreactivity
▶️ Isolated germinal centers
#KidneyWk #ISGDtweets #GlomerularDisease
▶️ B-cell activation and expanison
▶️ B-cell overdifferentiation and hiperreactivity
▶️ Isolated germinal centers
#KidneyWk #ISGDtweets #GlomerularDisease
Thrombotic microangiopathy in children - extensive differential @SethiRenalPath!
▶️ From STEC-HUS, TTP to atypical HUS genetics! 🧬
▶️ C3G and DDD involve distinct complement components - ApoE!
▶️ Searching for aHUS specific markers 🔍
#KidneyWk #GlomerularDisease
▶️ From STEC-HUS, TTP to atypical HUS genetics! 🧬
▶️ C3G and DDD involve distinct complement components - ApoE!
▶️ Searching for aHUS specific markers 🔍
#KidneyWk #GlomerularDisease
November 7, 2025 at 6:03 PM
Thrombotic microangiopathy in children - extensive differential @SethiRenalPath!
▶️ From STEC-HUS, TTP to atypical HUS genetics! 🧬
▶️ C3G and DDD involve distinct complement components - ApoE!
▶️ Searching for aHUS specific markers 🔍
#KidneyWk #GlomerularDisease
▶️ From STEC-HUS, TTP to atypical HUS genetics! 🧬
▶️ C3G and DDD involve distinct complement components - ApoE!
▶️ Searching for aHUS specific markers 🔍
#KidneyWk #GlomerularDisease
Membranous Nephropathy is not Adult-exclusive #ASN2025!
▶️ Pediatric patients are not 'little adults' @JeanHouMD - different clinical profiles, many unknown antigens! 🌟
▶️ Hot insights into new pediatric MN antigens @SethiRenalPath - Poster Pearls 👀
#GlomerularDisease
▶️ Pediatric patients are not 'little adults' @JeanHouMD - different clinical profiles, many unknown antigens! 🌟
▶️ Hot insights into new pediatric MN antigens @SethiRenalPath - Poster Pearls 👀
#GlomerularDisease
November 7, 2025 at 5:49 PM
Membranous Nephropathy is not Adult-exclusive #ASN2025!
▶️ Pediatric patients are not 'little adults' @JeanHouMD - different clinical profiles, many unknown antigens! 🌟
▶️ Hot insights into new pediatric MN antigens @SethiRenalPath - Poster Pearls 👀
#GlomerularDisease
▶️ Pediatric patients are not 'little adults' @JeanHouMD - different clinical profiles, many unknown antigens! 🌟
▶️ Hot insights into new pediatric MN antigens @SethiRenalPath - Poster Pearls 👀
#GlomerularDisease
Yesterday's highlights: IgA Nephropathy at Plenary Session!
▶️ 1. Impact of new tools by Dr. Vlado Perkovic - first #ASN2025 publication @kidneyint.bsky.social! 🔥
▶️ 2. Just published @nejm.org - Dr. Richard Lafayette on the ORIGIN 3 trial: Atacicept led to remarkable results! 🤯
#GlomerularDisease
▶️ 1. Impact of new tools by Dr. Vlado Perkovic - first #ASN2025 publication @kidneyint.bsky.social! 🔥
▶️ 2. Just published @nejm.org - Dr. Richard Lafayette on the ORIGIN 3 trial: Atacicept led to remarkable results! 🤯
#GlomerularDisease
November 7, 2025 at 3:28 PM
Yesterday's highlights: IgA Nephropathy at Plenary Session!
▶️ 1. Impact of new tools by Dr. Vlado Perkovic - first #ASN2025 publication @kidneyint.bsky.social! 🔥
▶️ 2. Just published @nejm.org - Dr. Richard Lafayette on the ORIGIN 3 trial: Atacicept led to remarkable results! 🤯
#GlomerularDisease
▶️ 1. Impact of new tools by Dr. Vlado Perkovic - first #ASN2025 publication @kidneyint.bsky.social! 🔥
▶️ 2. Just published @nejm.org - Dr. Richard Lafayette on the ORIGIN 3 trial: Atacicept led to remarkable results! 🤯
#GlomerularDisease
Reposted by International Society of Glomerular Disease
Spreading the word about the Importance and Power of Podocytes at @asnkidney.bsky.social Kidney Week in Houston. @isgd.bsky.social
November 4, 2025 at 8:09 PM
Spreading the word about the Importance and Power of Podocytes at @asnkidney.bsky.social Kidney Week in Houston. @isgd.bsky.social
ASN begins with an inspiring speech from Dr. Prabir Roy-Chaudhury, ASN president. A standing ovation for the new landscape of clinical trials in GD. ISGD is on the ground and will be reporting on the latest in GD. Follow and join the conversation. #ASN2025 #GlomerularDisease
November 6, 2025 at 3:43 PM
ASN begins with an inspiring speech from Dr. Prabir Roy-Chaudhury, ASN president. A standing ovation for the new landscape of clinical trials in GD. ISGD is on the ground and will be reporting on the latest in GD. Follow and join the conversation. #ASN2025 #GlomerularDisease
What an inspiring week at ESPN 2025 in Athens! We’re energized by powerful conversations with pediatric nephrology experts from 57 countries, and grateful to the ESPN team for uniting our global community.
#ESPN2025 #PediatricNephrology #ClinicalTrials #ISGD
#ESPN2025 #PediatricNephrology #ClinicalTrials #ISGD
October 19, 2025 at 6:53 PM
What an inspiring week at ESPN 2025 in Athens! We’re energized by powerful conversations with pediatric nephrology experts from 57 countries, and grateful to the ESPN team for uniting our global community.
#ESPN2025 #PediatricNephrology #ClinicalTrials #ISGD
#ESPN2025 #PediatricNephrology #ClinicalTrials #ISGD
📣 Are you ready for the newest in IgAN?
Join ISGD and Travere Therapeutics on Friday, October 24 at 12:00 PM ET for "PROTECTing What Matters: Targeting Endothelin-1 and Angiotensin II in IgA Nephropathy to Preserve Kidney Function."
Secure your spot: events.zoom.us/ev/AiBA7aMWF...
Join ISGD and Travere Therapeutics on Friday, October 24 at 12:00 PM ET for "PROTECTing What Matters: Targeting Endothelin-1 and Angiotensin II in IgA Nephropathy to Preserve Kidney Function."
Secure your spot: events.zoom.us/ev/AiBA7aMWF...
October 17, 2025 at 1:48 PM
📣 Are you ready for the newest in IgAN?
Join ISGD and Travere Therapeutics on Friday, October 24 at 12:00 PM ET for "PROTECTing What Matters: Targeting Endothelin-1 and Angiotensin II in IgA Nephropathy to Preserve Kidney Function."
Secure your spot: events.zoom.us/ev/AiBA7aMWF...
Join ISGD and Travere Therapeutics on Friday, October 24 at 12:00 PM ET for "PROTECTing What Matters: Targeting Endothelin-1 and Angiotensin II in IgA Nephropathy to Preserve Kidney Function."
Secure your spot: events.zoom.us/ev/AiBA7aMWF...
📢 A TSUNAMI of pediatric kidney clinical trials is upon us! 🌊
At @ESPNSociety in Athens, we kickstarted Time To Train, a Clinical Trialist Bootcamp to inspire the next generation of PIs and demystify the process!
In the golden age of nephrology, no child will be left behind!
At @ESPNSociety in Athens, we kickstarted Time To Train, a Clinical Trialist Bootcamp to inspire the next generation of PIs and demystify the process!
In the golden age of nephrology, no child will be left behind!
October 16, 2025 at 10:38 AM
📢 A TSUNAMI of pediatric kidney clinical trials is upon us! 🌊
At @ESPNSociety in Athens, we kickstarted Time To Train, a Clinical Trialist Bootcamp to inspire the next generation of PIs and demystify the process!
In the golden age of nephrology, no child will be left behind!
At @ESPNSociety in Athens, we kickstarted Time To Train, a Clinical Trialist Bootcamp to inspire the next generation of PIs and demystify the process!
In the golden age of nephrology, no child will be left behind!
The Time to Train team is present at ESPN in Athens, gearing up to educate the upcoming generation of clinical trialists. This timely initiative will serve as a crucial step towards the future of patient care and treatment.
#ESPN2025 #TimeToTrain #ISGD #ClinicalTrials
#ESPN2025 #TimeToTrain #ISGD #ClinicalTrials
October 14, 2025 at 1:26 PM
The Time to Train team is present at ESPN in Athens, gearing up to educate the upcoming generation of clinical trialists. This timely initiative will serve as a crucial step towards the future of patient care and treatment.
#ESPN2025 #TimeToTrain #ISGD #ClinicalTrials
#ESPN2025 #TimeToTrain #ISGD #ClinicalTrials
⛱️ At day 2 of the PARASOL Kickoff, experts united in a commitment to refine trial endpoints in APOL1 kidney disease & MN. A global effort through data sharing and collaboration! www.is-gd.org/en/news-from... #KidneyResearch #Innovation #AMKD #membranousnephropathy #KidneyHealth
Day 2: PARASOL APOL1 & MN Kickoff
PARASOL's day 2 meetings on APOL1 kidney disease and membranous nephropathy focused on biomarker strategies, data sharing, and international collaboration to advance research and clinical trials.
www.is-gd.org
October 13, 2025 at 6:11 PM
⛱️ At day 2 of the PARASOL Kickoff, experts united in a commitment to refine trial endpoints in APOL1 kidney disease & MN. A global effort through data sharing and collaboration! www.is-gd.org/en/news-from... #KidneyResearch #Innovation #AMKD #membranousnephropathy #KidneyHealth
Laura Mariani recapping PARASOL-FSGS project to a full house in Minneapolis as we kick off PARASOL MN and APOL1 projects! (PS we have diagnosed the carpet with Fabry disease) @miktmc.bsky.social @tobias-b-huber.bsky.social @jarcyzphd.bsky.social @utoronto.ca #APOL1nephropathy #MembranousNephropathy
October 10, 2025 at 1:45 AM
Laura Mariani recapping PARASOL-FSGS project to a full house in Minneapolis as we kick off PARASOL MN and APOL1 projects! (PS we have diagnosed the carpet with Fabry disease) @miktmc.bsky.social @tobias-b-huber.bsky.social @jarcyzphd.bsky.social @utoronto.ca #APOL1nephropathy #MembranousNephropathy
PARASOL Project is expanding focus to include biomarkers & endpoints in APOL1 kidney disease and primary MN as well as FSGS. Learn more: eu1.hubs.ly/H0nr8Lv0
@tobias-b-huber.bsky.social @miktmc.bsky.social @jarcyzphd.bsky.social @ohiostatemed.bsky.social @utoronto.ca @nu-nephrology.bsky.social
@tobias-b-huber.bsky.social @miktmc.bsky.social @jarcyzphd.bsky.social @ohiostatemed.bsky.social @utoronto.ca @nu-nephrology.bsky.social
PARASOL Project Expands Focus to APOL1, Membranous Nephropathy
PARASOL Project expands to focus on APOL1 kidney disease and primary membranous nephropathy, aiming to improve clinical trial endpoints for these conditions.
eu1.hubs.ly
October 3, 2025 at 1:26 PM
PARASOL Project is expanding focus to include biomarkers & endpoints in APOL1 kidney disease and primary MN as well as FSGS. Learn more: eu1.hubs.ly/H0nr8Lv0
@tobias-b-huber.bsky.social @miktmc.bsky.social @jarcyzphd.bsky.social @ohiostatemed.bsky.social @utoronto.ca @nu-nephrology.bsky.social
@tobias-b-huber.bsky.social @miktmc.bsky.social @jarcyzphd.bsky.social @ohiostatemed.bsky.social @utoronto.ca @nu-nephrology.bsky.social
Reposted by International Society of Glomerular Disease
Hamburg News: Study by Jan Czogalla & @puellesv.bsky.social & collaborators introduces a metabolically enhanced buffer + perfusion technique - opening a new avenue for kidney transplant organ preservation. @isgd.bsky.social
A technical advance in the field of organ transplantation!
@tobias-b-huber.bsky.social & team develop a metabolite-enhanced perfusion solution that improves kidney transplant viability, testing it across various species, including humans:
buff.ly/FyKsRiE
@tobias-b-huber.bsky.social & team develop a metabolite-enhanced perfusion solution that improves kidney transplant viability, testing it across various species, including humans:
buff.ly/FyKsRiE
September 29, 2025 at 7:59 PM
Hamburg News: Study by Jan Czogalla & @puellesv.bsky.social & collaborators introduces a metabolically enhanced buffer + perfusion technique - opening a new avenue for kidney transplant organ preservation. @isgd.bsky.social
Today on C3G Awareness Day, we spotlight our SEISMIC initiative where ISGD, NephCure, and CompCure convened leading experts at the SEISMIC summit to advance C3G diagnosis and treatment. Watch the highlights:
youtu.be/GJvgbtMT3xA
youtu.be/Un02dFXyn-w
#C3GAwarenessDay #C3G #ISGD #NephCure #CompCure
youtu.be/GJvgbtMT3xA
youtu.be/Un02dFXyn-w
#C3GAwarenessDay #C3G #ISGD #NephCure #CompCure
SEISMIC Film 1 - Strong foundation for critical actions to improve outcomes in C3G and IC-MPGN
YouTube video by CompCure
youtu.be
September 25, 2025 at 9:25 PM
Today on C3G Awareness Day, we spotlight our SEISMIC initiative where ISGD, NephCure, and CompCure convened leading experts at the SEISMIC summit to advance C3G diagnosis and treatment. Watch the highlights:
youtu.be/GJvgbtMT3xA
youtu.be/Un02dFXyn-w
#C3GAwarenessDay #C3G #ISGD #NephCure #CompCure
youtu.be/GJvgbtMT3xA
youtu.be/Un02dFXyn-w
#C3GAwarenessDay #C3G #ISGD #NephCure #CompCure
On this #C3GAwarenessDay, check out:
📺 Hot Topics in GN Online Symposium with the Indian Society of Nephrology: www.youtube.com/live/E0PnEj8...
🔊 Latest GN in 10 Podcast w/Carla Nester, focusing on C3G and complement-mediated diseases: www.is-gd.org/podcast
#C3G #GlomerularDisease #ISGD
📺 Hot Topics in GN Online Symposium with the Indian Society of Nephrology: www.youtube.com/live/E0PnEj8...
🔊 Latest GN in 10 Podcast w/Carla Nester, focusing on C3G and complement-mediated diseases: www.is-gd.org/podcast
#C3G #GlomerularDisease #ISGD
September 25, 2025 at 8:06 PM
On this #C3GAwarenessDay, check out:
📺 Hot Topics in GN Online Symposium with the Indian Society of Nephrology: www.youtube.com/live/E0PnEj8...
🔊 Latest GN in 10 Podcast w/Carla Nester, focusing on C3G and complement-mediated diseases: www.is-gd.org/podcast
#C3G #GlomerularDisease #ISGD
📺 Hot Topics in GN Online Symposium with the Indian Society of Nephrology: www.youtube.com/live/E0PnEj8...
🔊 Latest GN in 10 Podcast w/Carla Nester, focusing on C3G and complement-mediated diseases: www.is-gd.org/podcast
#C3G #GlomerularDisease #ISGD
Today is #C3GAwarenessDay! At ISGD, we stand with people living with this rare kidney disease. As a medical society for #GlomerularDisease experts, we're committed to raising awareness and moving the science forward to bring more hope and solutions to the C3G community. #C3G #ISGD
September 25, 2025 at 3:34 PM
Today is #C3GAwarenessDay! At ISGD, we stand with people living with this rare kidney disease. As a medical society for #GlomerularDisease experts, we're committed to raising awareness and moving the science forward to bring more hope and solutions to the C3G community. #C3G #ISGD
Calling all ESPN Attendees! 🚀 Announcing Time To Train: Clinical Trials Bootcamp for Investigator Training. Empowering nephrologists to lead groundbreaking trials in kidney disease. Join us, for hands-on training & mentorship: www.is-gd.org/time-to-trai... #TimeToTrain #ESPN2025
September 17, 2025 at 11:25 PM
Calling all ESPN Attendees! 🚀 Announcing Time To Train: Clinical Trials Bootcamp for Investigator Training. Empowering nephrologists to lead groundbreaking trials in kidney disease. Join us, for hands-on training & mentorship: www.is-gd.org/time-to-trai... #TimeToTrain #ESPN2025
We’re thrilled to be in Toronto presenting a Glomerular Disease Preceptorship in partnership with @sickkidsto.bsky.social and @utoronto.ca — Thanks to Christoph Licht and Heather Reich for organizing this outstanding program!
September 3, 2025 at 12:52 PM
We’re thrilled to be in Toronto presenting a Glomerular Disease Preceptorship in partnership with @sickkidsto.bsky.social and @utoronto.ca — Thanks to Christoph Licht and Heather Reich for organizing this outstanding program!